Export

EN
FR
Budesonide
Essential medicine status
Section:
25. Medicines acting on the respiratory tract 25.1. Antiasthmatic and medicines for chronic obstructive pulmonary disease
ATC codes: R03BA02
EMLc
Indication
Asthma ICD11 code: CA23
INN
Budesonide
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Respiratory > Inhalation > aerosol: 100 µg per dose ; 200 µg per dose
EML status history
First added in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
beclometasone (ATC codes: R03BA01)
ciclesonide (ATC codes: R03BA08)
flunisolide (ATC codes: R03BA03)
fluticasone (ATC codes: R03BA05)
mometasone (ATC codes: R03BA07)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Budesonide
DrugBank
Budesonide
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended removal of the separate square box listing for beclometasone on the EML, and including it instead as one of the specified therapeutic alternatives in the square box listing for budesonide. The Committee recommended beclometasone, ciclesonide, flunisolide, fluticasone and mometasone be specified as therapeutic alternatives under the square box listing for budesonide on the EML and EMLc.